Esperion Therapeutics Inc (ESPR) Common Stock USD0.001

Sell:$0.91Buy:$0.94$0.04 (4.54%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$0.91
Buy:$0.94
Change:$0.04 (4.54%)
Market closed | Prices delayed by at least 15 minutes
Sell:$0.91
Buy:$0.94
Change:$0.04 (4.54%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 April 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
8$0.96$7.71481,702
17 April 2025
Eric WarrenChief Level Officer
Sell
Tax related
108$0.98$105.62370,218
18 March 2025
Sheldon L KoenigPresident/CEO
Sell
Tax related
13,047$1.50$19,622.691,571,962
18 March 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
3,535$1.48$5,242.41481,710
18 March 2025
Eric WarrenChief Level Officer
Sell
Tax related
2,433$1.49$3,617.87370,326
19 February 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
11$1.86$20.46240,671
19 February 2025
Eric WarrenChief Level Officer
Sell
Tax related
239$1.87$446.45159,759
17 January 2025
Benjamin (Ben) HalladayCFO
Sell
Tax related
9$2.27$20.39240,682
17 January 2025
Eric WarrenChief Level Officer
Sell
Tax related
123$2.26$277.98159,998
17 December 2024
Sheldon L KoenigPresident/CEO
Sell
Tax related
12,447$2.47$30,694.30739,819

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 December 2024
Sheldon L KoenigPresident/CEO
Sell
Tax related
12,447$2.47$30,694.30739,819
17 September 2024
Sheldon L KoenigPresident/CEO
Sell
Tax related
14,550$1.80$26,131.80752,266
18 March 2025
Sheldon L KoenigPresident/CEO
Sell
Tax related
13,047$1.50$19,622.691,571,962
18 June 2024
JoAnne Micale FoodyOther Level A
Sell
Tax related
3,285$2.87$9,418.10273,779
17 December 2024
Benjamin (Ben) HalladayCFO
Sell
Tax related
3,245$2.42$7,865.88240,691

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.